These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 12764491

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
    Furesz J, Contreras G.
    Dev Biol Stand; 1993; 78():61-70. PubMed ID: 8388832
    [Abstract] [Full Text] [Related]

  • 4. A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine.
    Dragunsky E, Taffs R, Chernokhvostova Y, Nomura T, Hioki K, Gardner D, Norwood L, Levenbook I.
    Biologicals; 1996 Jun; 24(2):77-86. PubMed ID: 8889053
    [Abstract] [Full Text] [Related]

  • 5. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV, Fan L, Asher DM, Fibi MR, Dragunsky EM, Chumakov KM.
    Virology; 1999 May 25; 258(1):152-60. PubMed ID: 10329577
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neurovirulence.
    Wood D.
    Dev Biol Stand; 1999 May 25; 101():127-9. PubMed ID: 10566785
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of the new control methods for oral poliomyelitis vaccine.
    Grachev VP, Karganova GG, Rumyantsev AA, Ivanova OE, Eremeeva TP, Drozdov SG.
    Dev Biol (Basel); 2001 May 25; 105():211-7. PubMed ID: 11763330
    [Abstract] [Full Text] [Related]

  • 11. Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model.
    Thorley B, Kelly H, Nishimura Y, Yoon YK, Brussen KA, Roberts J, Shimizu H.
    J Clin Virol; 2009 Apr 25; 44(4):268-71. PubMed ID: 19269246
    [Abstract] [Full Text] [Related]

  • 12. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S, Ota Y, Koike S, Kurata T, Horie H, Nomura T, Hashizume S, Nomoto A.
    Virology; 1995 Feb 01; 206(2):1075-83. PubMed ID: 7856082
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alternative for the neurovirulence test.
    Schmeel A, Fibi MR.
    ALTEX; 1998 Feb 01; 15(5):22. PubMed ID: 11178532
    [Abstract] [Full Text] [Related]

  • 15. A collaborative study of the histopathological evaluation of the WHO neurovirulence test for poliovirus vaccines.
    Wood DJ, Heath AB, Marsden SA.
    Biologicals; 1994 Mar 01; 22(1):45-51. PubMed ID: 8068313
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
    Racaniello VR, Ren R, Bouchard M.
    Dev Biol Stand; 1993 Mar 01; 78():109-16. PubMed ID: 8388820
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.